AGT, ChemGenex Therapeutics Inc. deal

AGT will acquire ChemGenex for about 28 million shares of AGT, which values the deal at A$14.3 million ($10.5 million) based on AGT's pre-announcement close of A$0.51. ChemGenex's lead compound, Cefl...